Jillian Neary1, Michelle A Bulterys1, Emily A Ogutu2, Gabrielle O'Malley3, Anita A Otieno4, Vincent O Omondi4, Yu Wang3, Xinyi Zhai3, David A Katz3, Laura Oyiengo5, Dalton C Wamalwa6, Jennifer A Slyker1,3, Grace C John-Stewart1,3,7,8, Irene N Njuguna3,9, Anjuli D Wagner3. 1. Department of Epidemiology, University of Washington, Seattle, WA. 2. Gangarosa Department of Environmental Health, Emory University, Atlanta, GA. 3. Department of Global Health, University of Washington, Seattle, WA. 4. Kenya Pediatric Association, Nairobi, Kenya. 5. National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya. 6. Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya. 7. Department of Medicine, University of Washington, Seattle, WA. 8. Department of Pediatrics, University of Washington, Seattle, WA; and. 9. Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Abstract
BACKGROUND: Pediatric HIV testing remains suboptimal. The OraQuick test [saliva-based test (SBT)] is validated in pediatric populations ≥18 months. Understanding caregiver and health care worker (HCW) acceptability of pediatric SBT is critical for implementation. METHODS: A trained qualitative interviewer conducted 8 focus group discussions (FGDs): 4 with HCWs and 4 with caregivers of children seeking health services in western Kenya. FGDs explored acceptability of pediatric SBT and home- and facility-based SBT use. Two reviewers conducted consensus coding and thematic analyses of transcripts using Dedoose. RESULTS: Most HCWs but few caregivers had heard of SBT. Before seeing SBT instructions, both had concerns about potential HIV transmission through saliva, which were mostly alleviated after kit demonstration. Noted benefits of SBT included usability and avoiding finger pricks. Benefits of facility-based pediatric SBT included shorter client waiting and service time, higher testing coverage, and access to HCWs, while noted challenges included ensuring confidentiality. Benefits of caregivers using home-based SBT included convenience, privacy, decreased travel costs, increased testing, easier administration, and child comfort. Perceived challenges included not receiving counseling, disagreements with partners, child neglect, and negative emotional response to a positive test result. Overall, HCWs felt that SBT could be used for pediatric HIV testing but saw limited utility for caregivers performing SBT without an HCW present. Caregivers saw utility in home-based SBT but wanted easy access to counseling in case of a positive test result. CONCLUSIONS: SBT was generally acceptable to HCWs and caregivers and is a promising strategy to expand testing coverage.
BACKGROUND: Pediatric HIV testing remains suboptimal. The OraQuick test [saliva-based test (SBT)] is validated in pediatric populations ≥18 months. Understanding caregiver and health care worker (HCW) acceptability of pediatric SBT is critical for implementation. METHODS: A trained qualitative interviewer conducted 8 focus group discussions (FGDs): 4 with HCWs and 4 with caregivers of children seeking health services in western Kenya. FGDs explored acceptability of pediatric SBT and home- and facility-based SBT use. Two reviewers conducted consensus coding and thematic analyses of transcripts using Dedoose. RESULTS: Most HCWs but few caregivers had heard of SBT. Before seeing SBT instructions, both had concerns about potential HIV transmission through saliva, which were mostly alleviated after kit demonstration. Noted benefits of SBT included usability and avoiding finger pricks. Benefits of facility-based pediatric SBT included shorter client waiting and service time, higher testing coverage, and access to HCWs, while noted challenges included ensuring confidentiality. Benefits of caregivers using home-based SBT included convenience, privacy, decreased travel costs, increased testing, easier administration, and child comfort. Perceived challenges included not receiving counseling, disagreements with partners, child neglect, and negative emotional response to a positive test result. Overall, HCWs felt that SBT could be used for pediatric HIV testing but saw limited utility for caregivers performing SBT without an HCW present. Caregivers saw utility in home-based SBT but wanted easy access to counseling in case of a positive test result. CONCLUSIONS: SBT was generally acceptable to HCWs and caregivers and is a promising strategy to expand testing coverage.
Authors: Joanita Nangendo; Ekwaro A Obuku; Ismael Kawooya; John Mukisa; Annet Nalutaaya; Angella Musewa; Fred C Semitala; Charles A Karamagi; Joan N Kalyango Journal: PLoS One Date: 2017-08-23 Impact factor: 3.240
Authors: Chido Dziva Chikwari; Irene N Njuguna; Jillian Neary; Crissi Rainer; Belinda Chihota; Jennifer A Slyker; David A Katz; Dalton C Wamalwa; Laura Oyiengo; Tsitsi Bandason; Grace McHugh; Ethel Dauya; Hilda Mujuru; Kearsley A Stewart; Grace C John-Stewart; Rashida A Ferrand; Anjuli D Wagner Journal: J Acquir Immune Defic Syndr Date: 2019-12-01 Impact factor: 3.731
Authors: Madison McGuire; Anna de Waal; Angela Karellis; Ricky Janssen; Nora Engel; Rangarajan Sampath; Sergio Carmona; Alice Anne Zwerling; Marta Fernandez Suarez; Nitika Pant Pai Journal: EClinicalMedicine Date: 2021-08-13
Authors: Tanya Doherty; Hanani Tabana; Debra Jackson; Reshma Naik; Wanga Zembe; Carl Lombard; Sonja Swanevelder; Matthew P Fox; Anna Thorson; Anna Mia Ekström; Mickey Chopra Journal: BMJ Date: 2013-06-13
Authors: Michelle M Gill; Eliab K Natumanya; Heather J Hoffman; Gordon Okomo; Geoffrey Taasi; Laura Guay; Rose Masaba Journal: PLoS One Date: 2020-06-02 Impact factor: 3.240
Authors: Yu Wang; Jillian Neary; Xinyi Zhai; Anita Otieno; Gabrielle O'Malley; Hellen Moraa; Christine Kundu; Vincent Omondi; Emily R Begnel; Laura Oyiengo; Dalton Wamalwa; Grace C John-Stewart; Jennifer A Slyker; Anjuli D Wagner; Irene N Njuguna Journal: AIDS Behav Date: 2022-06-08